CT perfusion as a potential biomarker for pancreatic ductal adenocarcinoma during routine staging and restaging | | |
Impact of comprehensive family history and genetic analysis in the multidisciplinary pancreatic tumor clinic setting | | |
A clinicopathologic study of malignancy in VCP-associated multisystem proteinopathy | Orphanet Journal of Rare Diseases | 2022 |
Pancreatic Cancer and the Obesity Epidemic: A Narrative Review | Cureus | 2022 |
Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients with Locally Advanced and Borderline Resectable Pancreatic Cancer: Phase I Trial and Imaging-based Biomarker Validation | International Journal of Radiation Oncology Biology Physics | 2022 |
Preoperative therapy for pancreatic adenocarcinoma—precision beyond anatomy | Cancer | |
The Addition of Chemoradiation to Adjuvant Chemotherapy is Associated With Improved Survival Following Upfront Surgical Resection for Pancreatic Cancer With Nodal Metastases | Cancer Control | 2022 |
The Role of Type 2 Diabetes in Pancreatic Cancer | Cureus | 2022 |
Online information analysis on pancreatic cancer in Korea using structural topic model | Scientific Reports | 2022 |
The oral microbiome, pancreatic cancer and human diversity in the age of precision medicine | Microbiome | 2022 |
Pancreatic cancer | | 2023 |
Prospects of PARP Inhibitors in Treatment of BRCA-Mutated Pancreatic Cancer: a Literature Review | Kreativnaâ Hirurgiâ I Onkologiâ | 2022 |
Extracellular vesicle biomarkers for pancreatic cancer diagnosis: a systematic review and meta-analysis | BMC Cancer | 2022 |
Designing optimal allocations for cancer screening using queuing network models | PLoS Computational Biology | 2022 |
An Update on Common Pharmaceuticals in the Prevention of Pancreatic Cancer | Cureus | 2022 |
Magnetic Resonance Imaging of the Solid Parenchymal Organs | | 2015 |
The paradigm shift in treatment from Covid-19 to oncology with mRNA vaccines. | Cancer Treatment Reviews | 2022 |
Pathological and molecular diagnoses of early cancer with bile and pancreatic juice. | Digestive Endoscopy | 2022 |
High-dimensional deconstruction of pancreatic ductal adenocarcinoma identifies tumor microenvironmental communities associated with survival | | |
Response in mutation carrier with metastatic pancreatic adenocarcinoma treated with FOLFIRINOX. | BMJ Case Reports | 2022 |
Cinematic Rendering: Novel Tool for Improving Pancreatic Cancer Surgical Planning | Current Problems in Diagnostic Radiology | 2022 |
Association of standardized radiology reporting and management of abdominal CT and MRI with diagnosis of pancreatic cancer. | Clinical Gastroenterology and Hepatology | 2022 |
Decreasing length of stay and inpatient mortality associated with pancreatic cancer hospitalizations: A United States national survey from 2008 to 2017. | Pancreatology | 2022 |
A Brief Report: Comparative Evaluation of Online Spanish and English Content on Pancreatic Cancer Treatment. | Journal of Cancer Education | 2022 |
Prognostic impact of para-aortic lymph node status in resected pancreatic ductal adenocarcinoma and invasive intraductal papillary mucinous neoplasm - Time to consider a reclassification? | Surgical Oncology | 2022 |
Is There a Benefit to Adjuvant Chemotherapy in Resected, Early Stage Pancreatic Ductal Adenocarcinoma? | Annals of Surgical Oncology | 2022 |
Exploration of Novel Pathways Underlying Irreversible Electroporation Induced Anti-Tumor Immunity in Pancreatic Cancer. | Frontiers in Oncology | 2022 |
Hepatopancreaticobiliary Cancer in Older Adults with Frailty | | 2022 |
The impact of radiomics in diagnosis and staging of pancreatic cancer. | Therapeutic Advances in Gastrointestinal Endoscopy | 2022 |
Association of facility type with overall survival in patients with nonsurgically managed pancreatic cancer. | Future Oncology | 2022 |
Prediction of overall survival in patients with pancreatic ductal adenocarcinoma: histogram analysis of ADC value and correlation with pathological intratumoral necrosis. | BMC Medical Imaging | 2022 |
Chemotherapy in pancreatic ductal adenocarcinoma: When cytoreduction is the aim. A systematic review and meta-analysis. | Cancer Treatment Reviews | 2022 |
NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience. | Clinical and Translational Radiation Oncology | 2022 |
Landmark Series: Importance of Pancreatic Resection Margins. | Annals of Surgical Oncology | 2022 |
Deciphering CHFR Role in Pancreatic Ductal Adenocarcinoma | Frontiers in Medicine | 2021 |
The patient's perspective: a qualitative study of individual experience with decision-making, treatment, and recovery for resectable pancreatic cancer | Supportive Care in Cancer | 2021 |
Estimating the Financial Impact of Gene Therapy* | | |
Cystic Lesions of the Pancreas | | 2021 |
A New Era in the Adjuvant Treatment of Pancreatic Adenocarcinoma | Journal of Cancer Therapy | 2019 |
PIK3CA in KrasG12D/Trp53R172H Tumor Cells Promotes Immune Evasion by Limiting Infiltration of T Cells in a Model of Pancreatic Cancer | | |
Resectable and Borderline Resectable Pancreatic Cancer | | 2019 |
Treatment Sequencing for Resectable Disease | | 2019 |
Bile Duct Brush Cytology | Essentials in Cytopathology Series | 2019 |
Cytotoxic Therapy in Advanced Pancreatic Cancer: Where We Are and Where We Are Headed | | 2018 |
Citrullination in Inflammatory-Driven Carcinogenesis of the Colon | | 2017 |
Diabetes and the Exocrine Pancreas | | 2017 |
Chemotherapy in the Management of Pancreatic Cancer | | 2017 |
Pancreatic Cancer: Background and Clinical Evidence | | 2017 |
Pathologic Features of Primary Pancreatic Malignancies | Cancer Treatment and Research | 2016 |
Management of Pancreatic Cancer in the Elderly | Difficult Decisions in Surgery: an Evidence-based Approach | 2016 |